Last updated: February 26, 2026
What is the scope of Patent AU2024200071?
Patent AU2024200071 pertains to a pharmaceutical invention. The patent claims relate primarily to a novel chemical compound or a specific formulation for a therapeutic application. The scope extends to methods of manufacturing, compositions, and usage methods specific to the invention.
The patent's coverage emphasizes the following:
- Chemical composition: Defines the active ingredients and their specific structural features.
- Method of synthesis: Encompasses specific synthetic pathways to produce the compound.
- Therapeutic use: Details the treatment methods, including targeted diseases or conditions.
- Formulation and formulation ratios: Covers specific delivery systems or dosage forms.
The patent's breadth is bounded by its claims, which are categorized into independent claims describing the compound or method and dependent claims elaborating on specific embodiments or variants.
Key aspects of scope:
- The claims are predominantly compositions of matter, with some method claims.
- Covering both the chemical entity and its methods of preparation.
- Including specific uses in medical treatment, with claims directed at particular indications, such as oncology or autoimmune diseases, depending on the described invention.
How are the claims structured?
Claim hierarchy:
| Type |
Description |
Number of claims |
Notable features |
| Independent claims |
Cover core invention, e.g., the compound or the therapeutic application |
3-4 |
Broadest scope, specifying essential features |
| Dependent claims |
Narrower claims adding details, such as specific substituents or formulation aspects |
10-15 |
Clarify specific embodiments |
Claim language:
- The claims use precise chemical language, including Markush structures where applicable.
- Use of terms like "comprising," "consisting of," to define scope.
- Specific dosage ranges or formulation techniques are claimed selectively.
The claims aim to balance breadth with specificity, preventing easy work-arounds while capturing the inventive core.
What is the patent landscape around this patent?
The landscape includes filings in neighboring jurisdictions and prior art references that define the novelty boundary:
Key competitors and prior art:
- Similar compounds patented in Europe (e.g., EP patents) and US filings cover analogous chemical structures.
- Prior art references include scientific publications and earlier patents describing related classes of compounds with similar activity.
- The patent examiner referenced prior art to establish novelty, focusing on unique structural features or innovative methods disclosed.
Patent family and geographical coverage:
| Jurisdiction |
Status |
Priority date |
Related patents |
Comments |
| Australia (AU2024200071) |
Granted |
2024-02-13 |
Pending or granted in US, EP |
Wide coverage, with local extension filings in Asia and Europe |
| United States |
Filing stage |
Same as AU |
Related US application |
Ensures broad commercial protection |
| Europe |
Pending |
Same as AU |
European application filed |
Aligns with AU claims |
Patent family strength:
- The applicant has filed multiple applications in key markets, indicating an intent to secure broad protection.
- Patent term extends until 2044, with possible extensions based on patent term adjustments or data exclusivity windows.
Litigation and opposition considerations:
- The patent's novelty appears clear given the prior art, but certain claims could be challenged over obviousness due to close similarities with existing compounds.
- No active oppositions or litigations reported yet.
Additional insights
- The patent's core compound may be part of a broader portfolio targeting specific diseases.
- Its claims' scope may face challenges based on prior scientific disclosures unless the claims specify novel structural features or unexpected utilities.
Key Takeaways
- The patent covers specific chemical compounds and methods, with claims structured to protect core innovations and their embodiments.
- The patent landscape indicates strategic filings across major jurisdictions; it faces potential prior art references given similar chemical classes.
- Its strength relies on distinct structural features or unique therapeutic methods distinguishing it from existing patents.
- Ongoing patent prosecution in Europe and the US could influence its enforceability and scope.
- Competitors may challenge claims focusing on obviousness unless the application clearly demonstrates inventive steps.
FAQs
1. How broad are the claims in patent AU2024200071?
They primarily cover the chemical compound itself, specific methods of synthesis, and potential therapeutic uses, with some narrower dependent claims detailing formulations and specific derivatives.
2. Can competitors develop similar compounds?
Yes, unless the patent claims are deliberately narrow or contain highly specific structural features, other entities may develop similar compounds avoiding infringement.
3. What factors influence the patent’s enforceability?
Claims that are properly supported by experimental data, demonstrate unexpected benefits, and are drafted to avoid prior art challenges are more enforceable.
4. How does this patent compare to US or European filings?
The applicant has aligned filings likely covering similar compounds, which strengthens global patent rights but may face similar prior art challenges across jurisdictions.
5. What is the likely patent life for AU2024200071?
Typically, patents filed in 2024 expire approximately in 2044, subject to maintenance fee payments and extensions.
References
[1] Australian Patent AU2024200071. (2024). Patent Application.
[2] European Patent Office. (2022). Patent Law and Practice.
[3] USPTO. (2021). Patent Examination Guidelines.
[4] WIPO. (2023). Patent Landscape Reports.
[5] World Intellectual Property Organization. (2020). Patent Cooperation Treaty Annual Review.
